Help Shape the Future of Blood Lead Screening

CHAI and Renaissance Philanthropy are inviting public feedback on a draft Target Product Profile (TPP) for a rapid, low-cost, point-of-care screening test for elevated blood lead levels. The TPP is intended to send a clear signal to the market on what a fit-for-purpose blood lead screening tool should deliver, helping align developers, funders, procurers, and public health stakeholders around solutions that can improve access to testing and strengthen public health action on lead exposure.

The public comment period will be open from June 17 through July 8. Input is welcome from all interested individuals and organizations, including anyone with perspectives on lead exposure, diagnostics, screening, public health, implementation, product development, procurement, funding, policy, or related areas.

Access the draft TPP and comment form here: Public Comment: Target Product Profile for a Point-of-Care BLL Screening Test – Fill out form